Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-15 Sale | 2025-08-19 7:07 pm | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 19,500,000 | $0.01175 | $229,172 | 0 (Indirect) | View |
| 2024-12-23 Purchase | 2024-12-23 4:40 pm | Marker Therapeutics Inc. | MRKR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC BASKETT FOREST Chang Carmen Behbahani Ali Florence Anthony A. Jr. Makhzoumi Mohamad SANDELL SCOTT D Walker Paul Edward 10% Owner | 554,250 | $3.2 | $1,773,600 | 1,625,678 (Direct) | View |
| 2024-09-16 Purchase | 2024-09-17 8:24 pm | MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner | 500,000 | $16 | $8,000,000 | 3,614,486 (Indirect) | View |
| 2023-07-17 Purchase | 2023-07-19 7:06 pm | Savara Inc | SVRA | Behbahani Ali 10% Owner | 333,333 | $3 | $999,999 | 24,471,264 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-12 Other | 2025-08-14 6:22 pm | N/A N/A | Arcellx Inc. | ACLX | Behbahani Ali Director | 4,207 | $0 | 8,838 (Direct) | View |
| 2025-06-20 Option Award | 2025-06-20 4:21 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 6,170 | $2.33 | 4,525,907 (Direct) | View |
| 2025-06-13 Option Award | 2025-06-16 4:10 pm | N/A 2035-06-13 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 30,700 | $0 | 30,700 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 6:34 pm | N/A 2035-06-11 | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 30,550 | $0 | 30,550 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 4:40 pm | N/A 2035-06-10 | Korro Bio Inc. | KRRO | Behbahani Ali Director 10% Owner | 6,010 | $0 | 6,010 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:25 pm | N/A 2035-06-04 | Nkarta Inc. | NKTX | Behbahani Ali Director | 46,000 | $0 | 46,000 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:38 pm | N/A 2035-06-05 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2025-05-29 Option Award | 2025-05-30 4:33 pm | N/A 2035-05-29 | Arcellx Inc. | ACLX | Behbahani Ali Director | 9,174 | $0 | 9,174 (Direct) | View |
| 2025-03-21 Option Award | 2025-03-21 4:19 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 7,646 | $1.88 | 4,519,737 (Direct) | View |
| 2024-12-13 Option Award | 2024-12-16 5:09 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 5,750 | $2.5 | 4,512,091 (Direct) | View |
| 2024-09-20 Option Award | 2024-09-20 4:30 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 3,007 | $4.78 | 4,506,341 (Direct) | View |
| 2024-09-16 Conversion | 2024-09-17 8:24 pm | N/A N/A | MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner | 40,557,180 | $0 | 3,614,486 (Indirect) | View |
Ownership | 2024-09-12 7:24 pm | N/A N/A | MBX Biosciences Inc. | MBX | Behbahani Ali 10% Owner | 0 | $0 | 3,114,486 (Indirect) | View |
| 2024-07-01 Option Award | 2024-07-01 5:10 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 1,144,686 | $0 | 1,144,686 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 4:25 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 2,887 | $4.98 | 4,503,334 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:30 pm | N/A 2034-06-12 | Nkarta Inc. | NKTX | Behbahani Ali Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-13 8:12 pm | N/A 2034-06-12 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner | 22,100 | $0 | 22,100 (Direct) | View |
| 2024-06-11 Option Award | 2024-06-12 5:30 pm | N/A 2034-06-10 | Korro Bio Inc. | KRRO | Behbahani Ali Director 10% Owner | 5,190 | $0 | 5,190 (Direct) | View |
| 2024-06-04 Option Award(A) | 2024-06-07 5:25 pm | N/A 2034-06-04 | CVRx Inc. | CVRX | Behbahani Ali Director | 27,250 | $0 | 27,250 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-06 8:35 pm | N/A 2034-06-04 | CVRx Inc. | CVRX | Behbahani Ali Director | 20,961 | $0 | 20,961 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-06 6:20 pm | N/A 2034-06-05 | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 30,550 | $0 | 30,550 (Direct) | View |
| 2024-05-28 Option Award | 2024-06-06 5:28 pm | N/A 2034-05-28 | Arcellx Inc. | ACLX | Behbahani Ali Director | 8,011 | $0 | 8,011 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:50 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Behbahani Ali Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-04-22 Option Award | 2024-04-24 5:00 pm | N/A N/A | Korro Bio Inc. | KRRO | Behbahani Ali Director 10% Owner | 17,857 | $56 | 1,090,793 (Indirect) | View |
| 2024-03-15 Option Award | 2024-04-03 9:00 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 3,166 | $4.54 | 4,500,447 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:06 pm | 2025-01-15 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 40,950 | $0 | 40,950 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:40 pm | N/A 2023-12-14 | CVRx Inc. | CVRX | Behbahani Ali Director | 316 | $0 | 316 (Direct) | View |
| 2023-12-14 Exercise | 2023-12-18 4:40 pm | N/A N/A | CVRx Inc. | CVRX | Behbahani Ali Director | 316 | $0.237 | 316 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-15 4:48 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 4,455 | $2.73 | 4,497,281 (Direct) | View |
| 2023-11-03 Option Award | 2023-11-07 9:15 pm | N/A 2033-11-02 | Korro Bio Inc. | KRRO | Behbahani Ali Director 10% Owner | 1,088,936 | $0 | 1,088,936 (Direct) | View |
| 2023-09-15 Option Award | 2023-09-18 5:34 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director | 3,299 | $3.6 | 4,492,826 (Direct) | View |